hit counter
Accelerate Diagnostics, Inc. (AXDX) Stock News Sentiment & Price - Sentifly
AXDX - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Accelerate Diagnostics, Inc. (AXDX)

USA
Medical Laboratories & Research
NASDAQ
AXDX Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
AXDX Latest news
The Motley Fool
Positive
Are These 2 Companies Next for Short Squeezes?
2021-10-21 08:07

SmileDirectClub and Accelerate Diagnostics are super cheap right now, with very high short positions. Here's why the shorts might rupture.

PRNewsWire
Neutral
Accelerate Diagnostics Schedules Call to Review 3rd Quarter 2021 Results
2021-10-19 08:00

TUCSON, Ariz., Oct. 19, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Tuesday, November 9, 2021, at 4:30 p.m.

PRNewsWire
Neutral
Accelerate Diagnostics Announces Agreements to Exchange Approximately $51 Million in Principal Amount of Its 2.50% Convertible Senior Notes due 2023 for Common Stock
2021-09-23 09:15

TUCSON, Ariz., Sept. 23, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that it has entered into separate, privately negotiated exchange agreements with certain holders of its 2.50% Convertible Senior Notes due 2023 (the "Notes").

Seeking Alpha
Neutral
Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript
2021-08-08 10:51

Accelerate Diagnostics, Inc. (AXDX) CEO Jack Phillips on Q2 2021 Results - Earnings Call Transcript

Zacks Investment Research
Negative
Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates
2021-08-05 22:03

Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of -2.86% and -12.37%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

PRNewsWire
Neutral
Accelerate Diagnostics Reports Second Quarter 2021 Financial Results
2021-08-05 16:05

TUCSON, Ariz., Aug. 5, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced financial results for the second quarter for the period ended June 30, 2021.

PRNewsWire
Neutral
Accelerate Diagnostics Announces CE Mark and Availability in Europe of Fast Antimicrobial Susceptibility Test for Use with Existing ID Systems
2021-08-03 08:00

TUCSON, Ariz., Aug. 3, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that the new IVD configuration of its Accelerate PhenoTest® BC kit has been CE marked and is ready for use in Europe.

The Motley Fool
Positive
This In Vitro Diagnostics Company Is Poised to Capture Its Share of a Growing Market
2021-07-30 10:28

Its new system marks a groundbreaking advance in the field of testing for bloodstream infections.

Zacks Investment Research
Negative
Accelerate Diagnostics (AXDX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
2021-07-29 16:44

Accelerate Diagnostics (AXDX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PRNewsWire
Neutral
Accelerate Diagnostics Schedules Call to Review 2nd Quarter 2021 Results
2021-07-15 08:00

TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 5, 2021, at 4:30 p.m.

Loading more news...